Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

biOasis Technologies Inc.

www.bioasis.ca

Latest From biOasis Technologies Inc.

Appointments: CRISPR, KSQ Therapeutics, Immunocore, Cellectis, Translate Bio and biOasis

This week's roundup includes CEO appointments by CRISPR Therapeutics and KSQ Therapeutics, in addition to various other board and high-level appointments by Oncorus, Cellectis, BiOasis, Avillion and Revolution Medicines.

Appointments BioPharmaceutical

Appointments: Piramal Pharma, Oxeia, Artios Eyevensys and Bone Therapeutics

This week's roundup includes a new CEO for Oxeia, in addition to various other high-level appointments by Piramal Pharma Solutions, Bone Therapeutics, Kiadis and biOasis. Artios Pharma also welcomes AstraZeneca's former senior director bioscience, oncology to its team.

Appointments BioPharmaceutical

Appointments: Shire, Novartis, BenevolentAI, Akari Therapeutics and NDA

This week's roundup includes some movement in big pharma with the appointment of a chief financial officer by Shire, a chief digital officer by Novartis and BenevolentAI hiring GSK's head of a discovery performance unit.

Appointments BioPharmaceutical

Deals Shaping the Medical Industry, October 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in September 2016.

Deals BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
  • Therapeutic Areas
  • Cancer
  • Metabolic Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • Canada
  • Parent & Subsidiaries
  • biOasis Technologies Inc.
  • Senior Management
  • Mark Day, PhD, Pres. & CEO
    Christopher Lowe, CFO
    Doug Williams, EVP, CBO
    Mei Mei Tian, PhD, VP, Head, External Research
  • Contact Info
  • biOasis Technologies Inc.
    Phone: (604) 295-7014
    130-10691 Shellbridge Way
    Richmond, V6X 2W8
    Canada
Advertisement
Advertisement
UsernamePublicRestriction

Register